Burden of postmenopausal osteoporosis in Germany: Estimations from a disease model

被引:0
作者
A. Gauthier
J. A. Kanis
Y. Jiang
K. Dreinhöfer
M. Martin
J. Compston
F. Borgström
C. Cooper
E. McCloskey
机构
[1] Amaris, London
[2] University of Sheffield, Sheffield
[3] Abteilung für Muskuloskeletale Rehabilitation, Centrum für Sportwissenschaften und Sportmedizin (CSSB), Charité Universitätsmedizin Berlin, Berlin
[4] Abteilung Orthopädie und Unfallchirurgie, Medical Park Berlin Humboldtmühle, Berlin
[5] OptumInsight, Uxbridge Middlesex
[6] University of Cambridge, School of Clinical Medicine, Cambridge
[7] LIME/MMC, Karolinska Institutet, Stockholm
[8] University of Southampton, Southampton
[9] University of Oxford, Oxford
[10] Academic Unit of Bone Metabolism, Metabolic Bone Centre, University of Sheffield, Sheffield
[11] not available, London NW1 8NZ
关键词
Bone mineral density; Epidemiology; Fracture; Germany; Osteoporosis; T score;
D O I
10.1007/s11657-012-0099-7
中图分类号
学科分类号
摘要
This article describes the adaptation of a model assessing the incidence of osteoporotic fractures and prevalence of postmenopausal osteoporosis (PMO) in Germany. Purpose: The purpose of this paper is to estimate the epidemiological burden of PMO in Germany from 2010 to 2020. Methods: For each year of the study, the 'incident cohort' (women experiencing a first osteoporotic fracture) was identified and run through a Markov model using 1-year cycles until 2020. Health states were based on the number of fractures (1, 2 or ≥3) and deaths. Although the fracture site was not explicitly accounted for in the model structure, the site (hip, vertebral, non-hip non-vertebral) was tracked for each health state. Transition probabilities reflected the site-specific risk of death and of subsequent fractures. Model inputs included population size and life tables from 1970 to 2020, incidence of fracture and BMD by age in the general population (mean and standard deviation). Results: In 2010, the number of osteoporotic fractures was estimated at 349,560 in women aged 50 years or more, including 80,177 hip and 48,550 vertebral fractures. By 2020, the population is expected to grow by 13.1 %. As a result, the number of fractures is predicted to increase by 15.2 %. The improvement in life expectancy is predicted to lead to a relatively smaller increase in the number of deaths attributable to fractures (+12.8 %), but also to an increase in the prevalence of women with multiple prior fractures (+25.5 %). Conclusion: The PMO disease model, first developed for Sweden, was adapted to Germany. Due to the ageing of the population, the number of osteoporotic fractures is expected to increase markedly by +15.2 % by 2020. © 2012 International Osteoporosis Foundation and National Osteoporosis Foundation.
引用
收藏
页码:209 / 218
页数:9
相关论文
共 39 条
[1]  
Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis, Am J Med, 94, pp. 646-650, (1993)
[2]  
Kanis J.A., Assessment of Osteoporosis at the Primary Health-care Level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, (2007)
[3]  
Bone Health and Osteoporosis. A Report of the Surgeon General, (2004)
[4]  
Lane N.E., Epidemiology, etiology, and diagnosis of osteoporosis, Am J Obstet Gynecol, 194, (2006)
[5]  
Cummings S.R., Melton L.J., Epidemiology and outcomes of osteoporotic fractures, Lancet, 359, (2002)
[6]  
Report on Osteoporosis in the European Community, (1998)
[7]  
Icks A., Haastert M., Wildner M., Becker C., Meyer G., Trend of hip fracture incidence in Germany 1995-2004: A population-based study, Osteoporos Int, 19, pp. 1139-1145, (2008)
[8]  
Finnern H.W., Sykes D.P., The hospital cost of vertebral fractures in the EU: Estimates using national datasets, Osteoporos Int, 14, pp. 429-436, (2003)
[9]  
Haussler B., Gothe H., Gol D., Glaeske G., Pientka L., Felsenberg D., Epidemiology, treatment and costs of osteoporosis in Germany - The BoneEVA Study, Osteoporos Int, 18, pp. 77-84, (2007)
[10]  
Gauthier A., Kanis J.A., Martin M., Compston J., Borgstrom F., Cooper C., McCloskey E., Development and validation of a disease model for postmenopausal osteoporosis, Osteoporos Int, 22, pp. 771-780, (2011)